External suppression causes the low expression of the Cosmc gene in IgA nephropathy
- PMID: 18202089
- DOI: 10.1093/ndt/gfm781
External suppression causes the low expression of the Cosmc gene in IgA nephropathy
Abstract
Objective: IgA(1) aberrant O-glycosylation is one of the main pathogeneses of IgA nephropathy (IgAN), and the core I beta3-Gal-T-specific molecular chaperone (Cosmc) mRNA expression of IgAN patients was significantly decreased. This study tried to clarify whether the down-regulation was a result of genetic disorders or external suppressions.
Method: Sixty-five IgAN patients, 23 non-IgAN glomerulonephritis patients and 21 normal controls were recruited. Genomic DNA was extracted and the Cosmc gene was PCR amplified and directly sequenced. Peripheral B lymphocytes of IgAN patients and normal controls were isolated, and cultured with RPMI-1640 alone or with lipopolysaccharide (LPS) for 72 h. The Cosmc mRNA expression levels at baseline, after RPMI culture or RPMI + LPS treatment were measured by real-time RT-PCR.
Results: (1) The whole coding frame region of the Cosmc gene was successfully amplified and directly sequenced. Four single nucleotide polymorphisms were detected in two IgAN patients. Two were missense mutations and the others were silent mutations. However, they are different from each other, and unrelated to expression levels; (2) the baseline Cosmc mRNA expression in IgAN patients was significantly lower than normal controls (Ct(COSMC/GAPDH) 1.29 +/- 0.08 versus 1.20 +/- 0.01, 31% of normal controls); (3) the Cosmc mRNA expression level of IgAN patients was remarkably increased after the RPMI culture (1.22 +/- 0.12 versus 1.29 +/- 0.08, 219% of the baseline level), while not in normal controls and (4) treatment with LPS (culture with RPMI + LPS) could strongly inhibit the expression of Cosmc mRNA (1.25 +/- 0.01 versus 1.22 +/- 0.12, 61% of the RPMI treatment group).
Conclusion: No common Cosmc gene mutation was detected. Significantly increased Cosmc expression was observed in plasma-free culture, while LPS could significantly inhibit it, which suggested that it might not be genetic disorders but external suppression that causes the low Cosmc mRNA expression in IgAN.
Similar articles
-
Peripheral B lymphocyte beta1,3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy.J Intern Med. 2005 Nov;258(5):467-77. doi: 10.1111/j.1365-2796.2005.01558.x. J Intern Med. 2005. PMID: 16238683
-
No evidence for a role of cosmc-chaperone mutations in European IgA nephropathy patients.Nephrol Dial Transplant. 2009 Jan;24(1):321-4. doi: 10.1093/ndt/gfn538. Epub 2008 Oct 7. Nephrol Dial Transplant. 2009. PMID: 18840896
-
Astragalus membranaceus up-regulate Cosmc expression and reverse IgA dys-glycosylation in IgA nephropathy.BMC Complement Altern Med. 2014 Jun 18;14:195. doi: 10.1186/1472-6882-14-195. BMC Complement Altern Med. 2014. PMID: 24942185 Free PMC article. Clinical Trial.
-
[Progression in the mechanism of the Cosmc in IgA nephropathy].Zhonghua Er Ke Za Zhi. 2013 Jul;51(7):549-51. Zhonghua Er Ke Za Zhi. 2013. PMID: 24267143 Review. Chinese. No abstract available.
-
Methodological approaches to the analysis of IgA1 O-glycosylation in IgA nephropathy.J Nephrol. 1999 Mar-Apr;12(2):76-84. J Nephrol. 1999. PMID: 10378662 Review.
Cited by
-
A novel fluorescent assay for T-synthase activity.Glycobiology. 2011 Mar;21(3):352-62. doi: 10.1093/glycob/cwq168. Epub 2010 Oct 19. Glycobiology. 2011. PMID: 20959392 Free PMC article.
-
New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid.Int J Mol Sci. 2022 Mar 24;23(7):3525. doi: 10.3390/ijms23073525. Int J Mol Sci. 2022. PMID: 35408886 Free PMC article. Review.
-
Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy.Clin Exp Immunol. 2010 Jan;159(1):73-81. doi: 10.1111/j.1365-2249.2009.04045.x. Epub 2009 Nov 5. Clin Exp Immunol. 2010. PMID: 19891659 Free PMC article.
-
New insights into pathogenesis of IgA nephropathy.Int Urol Nephrol. 2022 Aug;54(8):1873-1880. doi: 10.1007/s11255-021-03094-0. Epub 2022 Jan 20. Int Urol Nephrol. 2022. PMID: 35048307 Review.
-
Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies.Theranostics. 2020 Sep 15;10(25):11462-11478. doi: 10.7150/thno.49778. eCollection 2020. Theranostics. 2020. PMID: 33052226 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous